RxDoctor Payments Data

Randall Murphy, MD

Orthopaedic Surgery · Montgomery, ALNPI 1528263415

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 86.8% of it on its own, with 23 other manufacturers making up the rest. Among orthopaedic surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$137,282in general payments, 2019–2025

Across 258 payments — averaging $532.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$119K
  • Encore Medical, LP$5K
  • Medical Device Business Services, Inc.$5K
  • Bioventus LLC$4K
  • Arthrex$2K
  • Prime Surgical, LLC$874
  • plus $2K from 18 others
$9,575in research payments, 2019–2025

Across 3 payments — averaging $3191.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$10K

What the payments were for

  • Consulting fees$47,38035%
  • Speaking & faculty fees$61,99845%
  • Travel & lodging$19,14914%
  • Food & beverage$7,5556%
  • Education$1,2001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew161$119,149
Encore Medical, LP23$4,585
Medical Device Business Services, Inc.7$4,583
Bioventus LLC10$3,961
Arthrex10$2,390
Prime Surgical, LLC3$874
Lima USA, Inc.1$400
Exactech, Inc.3$278
Johnson & Johnson(2 entities)7$254
Amgen(2 entities)12$180
Zimmer Biomet2$114
Acumed LLC1$103
Anika Therapeutics, Inc.1$93
Pacira Therapeutics, Inc.4$77
Vertex2$45
Pfizer3$40
ERMI LLC1$31
Xiros Inc1$26
Vericel Corporation1$23
Ossur Americas, Inc.1$20
Si-bone, Inc.1$16
Endo Pharmaceuticals Inc.1$13
Orthogenrx Inc.1$13
Medtronic1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$137,282 in reported general payments places this provider in the 95th percentile of 319 orthopaedic surgery providers in Alabama.

See all orthopaedic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$127,992
Medicare patients
271
Services billed
1,871

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Vancomycin Hcl12$2,265
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen199$1,095
Ibuprofen151$710
Cyclobenzaprine Hcl122$674
Meloxicam52$184
Methylprednisolone14$132
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$69
Tramadol Hcl26$67

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →